skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Tumors remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Material Type:
Artigo 		Adicionar ao Meu Espaço

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

Helleday, Thomas ; Bryant, Helen E ; Schultz, Niklas ; Thomas, Huw D ; Parker, Kayan M ; Flower, Dan ; Lopez, Elena ; Kyle, Suzanne ; Meuth, Mark ; Curtin, Nicola J

Nature, 2005-04, Vol.434 (7035), p.913-917 [Periódico revisado por pares]

London: Nature Publishing

Texto completo disponível

Citações Citado por
2
Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond
Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond
Material Type:
Artigo 		Adicionar ao Meu Espaço

Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond

Muller, Alexander J. ; Manfredi, Mark G. ; Zakharia, Yousef ; Prendergast, George C.

Seminars in immunopathology, 2019-01, Vol.41 (1), p.41-48 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
3
Proteomic characterization of EL4 lymphoma‐derived tumors upon chemotherapy treatment reveals potential roles for lysosomes and caspase‐6 during tumor cell death in vivo
Proteomic characterization of EL4 lymphoma‐derived tumors upon chemotherapy treatment reveals potential roles for lysosomes and caspase‐6 during tumor cell death in vivo
Material Type:
Artigo 		Adicionar ao Meu Espaço

Proteomic characterization of EL4 lymphoma‐derived tumors upon chemotherapy treatment reveals potential roles for lysosomes and caspase‐6 during tumor cell death in vivo

Kramer, David A. ; Eldeeb, Mohamed A. ; Wuest, Melinda ; Mercer, John ; Fahlman, Richard P.

Proteomics (Weinheim), 2017-06, Vol.17 (12), p.n/a [Periódico revisado por pares]

Germany: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
4
Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model
Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model

Kimura, Takayuki ; Kato, Yu ; Ozawa, Yoichi ; Kodama, Kotaro ; Ito, Junichi ; Ichikawa, Kenji ; Yamada, Kazuhiko ; Hori, Yusaku ; Tabata, Kimiyo ; Takase, Kazuma ; Matsui, Junji ; Funahashi, Yasuhiro ; Nomoto, Kenichi

Cancer science, 2018-12, Vol.109 (12), p.3993-4002 [Periódico revisado por pares]

England: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
5
New agents and regimens for diffuse large B cell lymphoma
New agents and regimens for diffuse large B cell lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

New agents and regimens for diffuse large B cell lymphoma

Wang, Liang ; Li, Lin-Rong ; Young, Ken H

Journal of hematology and oncology, 2020-12, Vol.13 (1), p.175-23, Article 175 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
6
When Is a Tumor Marker Ready for Prime Time? A Case Study of c-erbB-2 as a Predictive Factor in Breast Cancer
When Is a Tumor Marker Ready for Prime Time? A Case Study of c-erbB-2 as a Predictive Factor in Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

When Is a Tumor Marker Ready for Prime Time? A Case Study of c-erbB-2 as a Predictive Factor in Breast Cancer

YAMAUCHI, Hideko ; STEARNS, Vered ; HAYES, Daniel F

Journal of clinical oncology, 2001-04, Vol.19 (8), p.2334-2356 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
7
miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells
miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells

Chen, Gang ; Umelo, Ijeoma Adaku ; Lv, Shasha ; Teugels, Erik ; Fostier, Karel ; Kronenberger, Peter ; Dewaele, Alex ; Sadones, Jan ; Geers, Caroline ; De Grève, Jacques Chellappan, Srikumar P.

PloS one, 2013-03, Vol.8 (3), p.e60317-e60317 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por
8
Preclinical and clinical studies of anticancer agent‐incorporating polymer micelles
Preclinical and clinical studies of anticancer agent‐incorporating polymer micelles
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preclinical and clinical studies of anticancer agent‐incorporating polymer micelles

Matsumura, Yasuhiro ; Kataoka, Kazunori

Cancer science, 2009-04, Vol.100 (4), p.572-579 [Periódico revisado por pares]

Melbourne, Australia: Blackwell Publishing Asia

Texto completo disponível

Citações Citado por
9
Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy
Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy

Hua, Hui ; Kong, Qingbin ; Yin, Jie ; Zhang, Jin ; Jiang, Yangfu

Journal of hematology and oncology, 2020-06, Vol.13 (1), p.64-64, Article 64 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
10
Progranulin promotes Temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness
Progranulin promotes Temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness
Material Type:
Artigo 		Adicionar ao Meu Espaço

Progranulin promotes Temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness

Bandey, I ; Chiou, S-H ; Huang, A-P ; Tsai, J-C ; Tu, P-h

Oncogene, 2015-04, Vol.34 (14), p.1853-1864 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (42.755)
  2. Revistas revisadas por pares (42.719)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (44.071)
  2. Anais de Congresso  (94)
  3. Livros  (65)
  4. Book Chapters  (16)
  5. magazinearticle  (5)
  6. Newsletter Articles  (4)
  7. Mais opções open sub menu

Assunto 

  1. Science & Technology  (40.838)
  2. Life Sciences & Biomedicine  (37.946)
  3. Humans  (37.172)
  4. Biological And Medical Sciences  (31.732)
  5. Medical Sciences  (31.556)
  6. Oncology  (30.714)
  7. Pharmacology. Drug Treatments  (26.425)
  8. Antineoplastic Agents  (26.358)
  9. Female  (18.455)
  10. Animals  (17.202)
  11. Cell Line, Tumor  (14.287)
  12. Antineoplastic Agents - Pharmacology  (13.884)
  13. Mice  (12.914)
  14. Male  (11.791)
  15. Middle Aged  (8.964)
  16. Chemotherapy  (8.365)
  17. Cancer Research  (7.893)
  18. Cancer  (7.871)
  19. Aged  (7.721)
  20. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1973  (20)
  2. 1973Até1986  (110)
  3. 1987Até1998  (1.379)
  4. 1999Até2011  (24.618)
  5. Após 2011  (18.173)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (44.249)
  2. Japonês  (11.565)
  3. Alemão  (26)
  4. Holandês  (8)
  5. Russo  (6)
  6. Norueguês  (6)
  7. Português  (6)
  8. Chinês  (3)
  9. Polonês  (1)
  10. Francês  (1)
  11. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.